SCHEMBL18610128

SCHEMBL18610128

COc1cccc(CNC(C)c2cc(-c3ccc(C)c(CCC(=O)OC(C)C)c3)c3ccccc3n2)c1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ CASR P41180 5/20 0.42
▸ LMNA P02545 3/20 0.40
▸ HTT P42858 2/20 0.40
▸ ACP1 P24666 1/20 0.39
▸ MMP13 P45452 2/20 0.39
▸ ADORA3 P0DMS8 2/20 0.39
▸ MAOB P27338 2/20 0.39
▸ ADORA2A P29274 2/20 0.39
▸ ADORA2B P29275 2/20 0.39
▸ ADORA1 P30542 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ LTB4R Q15722 1/20 0.38
▸ APP P05067 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18609844 0.87 CASR (0.39) SMN1; SMN2CASRLMNAHTTACP1
SCHEMBL18610126 0.87 LTB4R (0.38) SMN1; SMN2CASRMAPTL3MBTL1LTB4R
SCHEMBL18610314 0.86 SMN1; SMN2 (0.44) SMN1; SMN2CASRLMNAHTTACP1
SCHEMBL18609641 0.85 CASR (0.39) CASRLMNAMAPTPOLB
SCHEMBL18610032 0.85 CASR (0.41) SMN1; SMN2CASRLMNAHTTACP1
SCHEMBL18609918 0.84 LMNA (0.47) SMN1; SMN2CASRLMNAHTTACP1
SCHEMBL18610127 0.79 LMNA (0.42) SMN1; SMN2CASRLMNAHTTACP1
SCHEMBL18609805 0.79 LTB4R (0.40) CASRLTB4R
SCHEMBL18609838 0.79 ALDH1A1 (0.40) SMN1; SMN2CASRLMNAHTTACP1
SCHEMBL18609947 0.79 HSD17B1 (0.35) CASRLMNAACP1ADORA3MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017037616-A1 ARYLALKYLAMINE COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS LUPIN LIMITED (IN) 2017-03-09 — — WO disclosed
Send feedback